[1]Bagley;Thomas;Rudo;Spencer;Doorley;Ossipov;Jerussi;Benvenga;Spaulding[JournalofMedicinalChemistry,1991,vol.34,#2,p.827-841]
[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2004/113303,2004,A1Locationinpatent:Page21-22
[1]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC-WO2006/19716,2006,A1Locationinpatent:Page/Pagecolumn177;178
306934-89-4
730992-77-5
321309-29-9
13188-89-1 | H-D-Asp(obzl)-oh | AA000ZT1 | MFCD00077100
1321-14-8 | Potassium guaiacolsulfonate | AA00104Y | MFCD00053298
132295-44-4 | 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy-, (2S,3R,4R,5R)- | AA0010EZ | MFCD06804502
13256-22-9 | Acetic acid, 2-(methylnitrosoamino)- | AA0010RG | MFCD00152671
13280-03-0 | 2-Butynoic acid, 4-chloro- | AA00114O | MFCD19228101
133-13-1 | Diethyl ethylmalonate | AA0011EO | MFCD00009167
1363382-31-3 | 6-Bromo-2,4-dichlorofuro[3,2-d]pyrimidine | AA0011N5 | MFCD20258032
1365271-73-3 | 1-Cyclohexyl-6,7-difluoro-1,2,3-benzotriazole | AA0011W5 | MFCD21609578
1366131-38-5 | 5-Bromo-2-methoxy-4-methylpyridin-3-amine | AA001224 | MFCD22192426
136834-21-4 | 5'-O-Dmt-n6-benzoyl-2'-fluoro-2'-deoxyadenosine | AA0012CL | MFCD15145191